240 related articles for article (PubMed ID: 31236617)
1. Regulation of gut microbiota in Alzheimer's disease mice by silibinin and silymarin and their pharmacological implications.
Shen L; Liu L; Li XY; Ji HF
Appl Microbiol Biotechnol; 2019 Sep; 103(17):7141-7149. PubMed ID: 31236617
[TBL] [Abstract][Full Text] [Related]
2. Bidirectional interactions between curcumin and gut microbiota in transgenic mice with Alzheimer's disease.
Sun ZZ; Li XY; Wang S; Shen L; Ji HF
Appl Microbiol Biotechnol; 2020 Apr; 104(8):3507-3515. PubMed ID: 32095862
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State.
Shen L; Liu L; Ji HF
J Alzheimers Dis; 2017; 56(1):385-390. PubMed ID: 27911317
[TBL] [Abstract][Full Text] [Related]
4. Jatrorrhizine Balances the Gut Microbiota and Reverses Learning and Memory Deficits in APP/PS1 transgenic mice.
Wang S; Jiang W; Ouyang T; Shen XY; Wang F; Qu YH; Zhang M; Luo T; Wang HQ
Sci Rep; 2019 Dec; 9(1):19575. PubMed ID: 31862965
[TBL] [Abstract][Full Text] [Related]
5. Silibinin: a novel inhibitor of Aβ aggregation.
Yin F; Liu J; Ji X; Wang Y; Zidichouski J; Zhang J
Neurochem Int; 2011 Feb; 58(3):399-403. PubMed ID: 21185897
[TBL] [Abstract][Full Text] [Related]
6. Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for the treatment of Alzheimer's disease.
Duan S; Guan X; Lin R; Liu X; Yan Y; Lin R; Zhang T; Chen X; Huang J; Sun X; Li Q; Fang S; Xu J; Yao Z; Gu H
Neurobiol Aging; 2015 May; 36(5):1792-807. PubMed ID: 25771396
[TBL] [Abstract][Full Text] [Related]
7. Antioxidative and Anti-Apoptotic Roles of Silibinin in Reversing Learning and Memory Deficits in APP/PS1 Mice.
Bai D; Jin G; Yin S; Zou D; Zhu Q; Yang Z; Liu X; Ren L; Sun Y; Gan S
Neurochem Res; 2017 Dec; 42(12):3439-3445. PubMed ID: 28852940
[TBL] [Abstract][Full Text] [Related]
8. High-altitude Tibetan fermented milk ameliorated cognitive dysfunction by modified gut microbiota in Alzheimer's disease transgenic mice.
Liu J; Yu C; Li R; Liu K; Jin G; Ge R; Tang F; Cui S
Food Funct; 2020 Jun; 11(6):5308-5319. PubMed ID: 32458851
[TBL] [Abstract][Full Text] [Related]
9. Fructooligosaccharides Ameliorating Cognitive Deficits and Neurodegeneration in APP/PS1 Transgenic Mice through Modulating Gut Microbiota.
Sun J; Liu S; Ling Z; Wang F; Ling Y; Gong T; Fang N; Ye S; Si J; Liu J
J Agric Food Chem; 2019 Mar; 67(10):3006-3017. PubMed ID: 30816709
[TBL] [Abstract][Full Text] [Related]
10. Improving Alzheimer's disease by altering gut microbiota in tree shrews with ginsenoside Rg1.
Wang L; Lu J; Zeng Y; Guo Y; Wu C; Zhao H; Zheng H; Jiao J
FEMS Microbiol Lett; 2020 Feb; 367(4):. PubMed ID: 31950993
[TBL] [Abstract][Full Text] [Related]
11. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model.
Kim MS; Kim Y; Choi H; Kim W; Park S; Lee D; Kim DK; Kim HJ; Choi H; Hyun DW; Lee JY; Choi EY; Lee DS; Bae JW; Mook-Jung I
Gut; 2020 Feb; 69(2):283-294. PubMed ID: 31471351
[TBL] [Abstract][Full Text] [Related]
12. Silymarin attenuated the amyloid β plaque burden and improved behavioral abnormalities in an Alzheimer's disease mouse model.
Murata N; Murakami K; Ozawa Y; Kinoshita N; Irie K; Shirasawa T; Shimizu T
Biosci Biotechnol Biochem; 2010; 74(11):2299-306. PubMed ID: 21071836
[TBL] [Abstract][Full Text] [Related]
13. Silibinin ameliorates anxiety/depression-like behaviors in amyloid β-treated rats by upregulating BDNF/TrkB pathway and attenuating autophagy in hippocampus.
Song X; Liu B; Cui L; Zhou B; Liu W; Xu F; Hayashi T; Hattori S; Ushiki-Kaku Y; Tashiro SI; Ikejima T
Physiol Behav; 2017 Oct; 179():487-493. PubMed ID: 28735062
[TBL] [Abstract][Full Text] [Related]
14. Natural Dietary Compound Xanthohumol Regulates the Gut Microbiota and Its Metabolic Profile in a Mouse Model of Alzheimer's Disease.
Liu W; He K; Wu D; Zhou L; Li G; Lin Z; Yang X; Liu J; Pui Man Hoi M
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209070
[TBL] [Abstract][Full Text] [Related]
15. HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease.
Zhu X; Wang S; Yu L; Jin J; Ye X; Liu Y; Xu Y
Aging Cell; 2017 Oct; 16(5):1073-1082. PubMed ID: 28771976
[TBL] [Abstract][Full Text] [Related]
16. Altered Gut Microbiota in a Mouse Model of Alzheimer's Disease.
Zhang L; Wang Y; Xiayu X; Shi C; Chen W; Song N; Fu X; Zhou R; Xu YF; Huang L; Zhu H; Han Y; Qin C
J Alzheimers Dis; 2017; 60(4):1241-1257. PubMed ID: 29036812
[TBL] [Abstract][Full Text] [Related]
17. Silibinin attenuates amyloid beta(25-35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice.
Lu P; Mamiya T; Lu LL; Mouri A; Niwa M; Hiramatsu M; Zou LB; Nagai T; Ikejima T; Nabeshima T
J Pharmacol Exp Ther; 2009 Oct; 331(1):319-26. PubMed ID: 19638571
[TBL] [Abstract][Full Text] [Related]
18. Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment.
Tota S; Kamat PK; Shukla R; Nath C
Behav Brain Res; 2011 Aug; 221(1):207-15. PubMed ID: 21382422
[TBL] [Abstract][Full Text] [Related]
19. The Therapeutic Effect of Silymarin and Silibinin on Depression and Anxiety Disorders and Possible Mechanism in the Brain: A Systematic Review.
Rostamian S; Heidari-Soureshjani S; Sherwin CMT
Cent Nerv Syst Agents Med Chem; 2023; 23(2):86-94. PubMed ID: 37612866
[TBL] [Abstract][Full Text] [Related]
20. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression.
Wang X; Sun G; Feng T; Zhang J; Huang X; Wang T; Xie Z; Chu X; Yang J; Wang H; Chang S; Gong Y; Ruan L; Zhang G; Yan S; Lian W; Du C; Yang D; Zhang Q; Lin F; Liu J; Zhang H; Ge C; Xiao S; Ding J; Geng M
Cell Res; 2019 Oct; 29(10):787-803. PubMed ID: 31488882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
